The Centers for Medicare & Medicaid Services canceled roughly 315,000 Affordable Care Act marketplace plans covering more than 760,000 people in August, escalating a federal campaign against enrollments the Trump administration says were unauthorized, ineligible or tied to people it could not verify.
The action, announced Tuesday, combines large-scale coverage cancellations with a temporary halt on new registrations by agents and brokers who were not approved for the 2026 plan year. Administration officials estimate the cancellations will recover about $2.2 billion in advance premium tax-credit payments, according to Reuters. That estimate is an administration projection, not a completed audit of money already returned to the Treasury.
The scope makes the decision consequential beyond health policy. It tests how aggressively the government can use data matching and program-integrity tools to stop suspected fraud while protecting eligible consumers from losing coverage through error. The affected group includes both people the administration described as nonexistent and real people it says did not meet eligibility rules or were enrolled without their knowledge.
A broad cancellation and a second review
Vice President JD Vance said the cancellations covered about 760,000 people and that another 419,000 enrollments would receive additional verification, the Associated Press reported. Officials cited missing or unverified citizenship and immigration documentation, questionable applications and cases in which consumers could not be reached.
CMS said it would keep working with insurers to identify suspected unauthorized enrollment, cancel cases it confirms and recover associated subsidies. The agency has also increased enforcement against intermediaries. More than 200 agents and brokers received termination notices earlier this year, and another 569 received notices this summer after submitting what CMS called statistically implausible rates of applications lacking key identifying information, according to Scripps News.
Evidence of a genuine vulnerability predates Tuesday's announcement. The Government Accountability Office found that federal marketplace controls did not always prevent unauthorized actions, while consumer complaints about unauthorized enrollments and plan switches grew more than fourfold from 2023 through 2025. GAO recommended stronger consent verification, including possible one-time passcodes, limits on record access and fuller notifications to consumers. The July report said those recommendations remained open.
New brokers face a national pause
An interim final rule effective Sept. 22 pauses registration for agents and brokers who lack 2026 exchange agreements and want to participate through the federally facilitated marketplaces in 2027. The moratorium runs until Feb. 1, 2027, unless CMS changes or ends it earlier. It does not apply to registrations on state-run exchanges or to web-brokers.
HHS invoked a legal exception allowing the rule to take effect without the usual advance notice-and-comment period, arguing that delay would be impracticable and contrary to the public interest. The agency is still accepting comments through Nov. 21. In the 56-page rule, CMS said the pause would give it time to strengthen identity proofing, consumer authorization and monitoring before new brokers gain access to federal systems.
The rule also supplies important limits to the government's figures. CMS estimated that unauthorized enrollment could produce between $1.5 billion and $6.6 billion in improper federal spending for 2026. Its high-end calculation relies partly on the difference between the share of subsidized marketplace plans and off-marketplace plans that record no medical claims. CMS acknowledged that zero use does not prove an enrollment was unauthorized; healthy people may legitimately go a full year without filing a claim.
Fraud risk is documented, but scale remains disputed
A separate GAO examination offers strong evidence that weaknesses exist without establishing how widespread fraud is across the entire marketplace. In covert testing, the marketplace approved subsidized coverage for nearly all 24 fictitious applicants GAO submitted for 2024 and 2025. But GAO explicitly warned that the test was illustrative and could not be generalized to the enrollee population.
That distinction matters for the 760,000 people affected. Fraud, administrative error, missing documentation and enrollment without a person's informed consent are not interchangeable findings. The public record released Tuesday does not provide individual case files, an error rate or a detailed breakdown of how many cancellations fell into each category. Policy experts cited by AP supported removing clearly fraudulent enrollments but questioned whether the process reliably separated them from eligible people.
The administration's action builds on a broader CMS enforcement effort. In January, the agency said it had ended subsidies for nearly 1.5 million people during the prior year because of concurrent Medicaid or Children's Health Insurance Program coverage, failure to reconcile prior tax credits or unauthorized enrollment. That CMS accounting grouped several different eligibility and compliance processes, underscoring why headline fraud totals require careful interpretation.
The immediate policy question is whether CMS can correct real weaknesses without creating a new access problem. Brokers help many consumers compare plans and complete complicated applications, so a blanket pause may reduce assistance during the next enrollment season. The National Association of Benefits and Insurance Professionals argued that targeted enforcement would better protect consumers and legitimate agents. CMS countered that returning brokers should provide adequate capacity while stronger safeguards are built.
For consumers, the central risk runs in both directions: an unauthorized enrollment can cause unwanted plan changes, medical-bill complications or tax problems, while an erroneous cancellation can interrupt treatment and access to prescriptions. The administration has made a major claim about savings and fraud prevention. Demonstrating the policy's success will require transparent error rates, appeal outcomes, recovered funds and evidence that eligible people were not swept out with fraudulent accounts.
